IBDEI0J5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8991,1,4,0)
 ;;=4^ENDOMETRIOSIS NOS
 ;;^UTILITY(U,$J,358.3,8991,1,5,0)
 ;;=5^617.9
 ;;^UTILITY(U,$J,358.3,8991,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,8992,0)
 ;;=628.9^^38^508^6
 ;;^UTILITY(U,$J,358.3,8992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8992,1,4,0)
 ;;=4^FEMALE INFERTILITY NOS
 ;;^UTILITY(U,$J,358.3,8992,1,5,0)
 ;;=5^628.9
 ;;^UTILITY(U,$J,358.3,8992,2)
 ;;=^62820
 ;;^UTILITY(U,$J,358.3,8993,0)
 ;;=611.6^^38^508^7
 ;;^UTILITY(U,$J,358.3,8993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8993,1,4,0)
 ;;=4^GALACTORRHEA-NONOBSTET
 ;;^UTILITY(U,$J,358.3,8993,1,5,0)
 ;;=5^611.6
 ;;^UTILITY(U,$J,358.3,8993,2)
 ;;=^270460
 ;;^UTILITY(U,$J,358.3,8994,0)
 ;;=256.1^^38^508^14
 ;;^UTILITY(U,$J,358.3,8994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8994,1,4,0)
 ;;=4^OVARIAN HYPERFUNC NEC
 ;;^UTILITY(U,$J,358.3,8994,1,5,0)
 ;;=5^256.1
 ;;^UTILITY(U,$J,358.3,8994,2)
 ;;=^267878
 ;;^UTILITY(U,$J,358.3,8995,0)
 ;;=704.1^^38^508^9
 ;;^UTILITY(U,$J,358.3,8995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8995,1,4,0)
 ;;=4^HIRSUTISM
 ;;^UTILITY(U,$J,358.3,8995,1,5,0)
 ;;=5^704.1
 ;;^UTILITY(U,$J,358.3,8995,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,8996,0)
 ;;=627.2^^38^508^11
 ;;^UTILITY(U,$J,358.3,8996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8996,1,4,0)
 ;;=4^MENOPAUSE
 ;;^UTILITY(U,$J,358.3,8996,1,5,0)
 ;;=5^627.2
 ;;^UTILITY(U,$J,358.3,8996,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,8997,0)
 ;;=256.31^^38^508^10
 ;;^UTILITY(U,$J,358.3,8997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8997,1,4,0)
 ;;=4^MANOPAUSE,PREMATURE
 ;;^UTILITY(U,$J,358.3,8997,1,5,0)
 ;;=5^256.31
 ;;^UTILITY(U,$J,358.3,8997,2)
 ;;=^75883
 ;;^UTILITY(U,$J,358.3,8998,0)
 ;;=256.39^^38^508^12
 ;;^UTILITY(U,$J,358.3,8998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8998,1,4,0)
 ;;=4^OTHER OVARIAN FAILURE
 ;;^UTILITY(U,$J,358.3,8998,1,5,0)
 ;;=5^256.39
 ;;^UTILITY(U,$J,358.3,8998,2)
 ;;=^330824
 ;;^UTILITY(U,$J,358.3,8999,0)
 ;;=256.4^^38^508^16
 ;;^UTILITY(U,$J,358.3,8999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8999,1,4,0)
 ;;=4^POLYCYSTIC OVARIES
 ;;^UTILITY(U,$J,358.3,8999,1,5,0)
 ;;=5^256.4
 ;;^UTILITY(U,$J,358.3,8999,2)
 ;;=^96086
 ;;^UTILITY(U,$J,358.3,9000,0)
 ;;=616.10^^38^508^20
 ;;^UTILITY(U,$J,358.3,9000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9000,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,9000,1,5,0)
 ;;=5^616.10
 ;;^UTILITY(U,$J,358.3,9000,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,9001,0)
 ;;=627.3^^38^508^21
 ;;^UTILITY(U,$J,358.3,9001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9001,1,4,0)
 ;;=4^VAGINITIS,ATROPHIC
 ;;^UTILITY(U,$J,358.3,9001,1,5,0)
 ;;=5^627.3
 ;;^UTILITY(U,$J,358.3,9001,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,9002,0)
 ;;=112.1^^38^508^22
 ;;^UTILITY(U,$J,358.3,9002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9002,1,4,0)
 ;;=4^VAGINITIS,CANDIDAL
 ;;^UTILITY(U,$J,358.3,9002,1,5,0)
 ;;=5^112.1
 ;;^UTILITY(U,$J,358.3,9002,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,9003,0)
 ;;=131.01^^38^508^23
 ;;^UTILITY(U,$J,358.3,9003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9003,1,4,0)
 ;;=4^VAGINITIS,TRICHOMONAL
 ;;^UTILITY(U,$J,358.3,9003,1,5,0)
 ;;=5^131.01
 ;;^UTILITY(U,$J,358.3,9003,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,9004,0)
 ;;=256.9^^38^508^13
 ;;^UTILITY(U,$J,358.3,9004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9004,1,4,0)
 ;;=4^OVARIAN DYSFUNCTION NOS
 ;;^UTILITY(U,$J,358.3,9004,1,5,0)
 ;;=5^256.9
 ;;^UTILITY(U,$J,358.3,9004,2)
 ;;=^267882
 ;;^UTILITY(U,$J,358.3,9005,0)
 ;;=239.7^^38^508^4
 ;;^UTILITY(U,$J,358.3,9005,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0J5
